pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    JANX-007
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JANX Janux Therapeutics, Inc.
  • Phase 1
    JANX-008
    Head And Neck Squamous Cell Carcinoma (HNSC)$JANX Janux Therapeutics, Inc.
  • Phase 2
    JBI-778
    Adenoid Cystic Carcinoma (ACC) Jubilant Therapeutics Inc
← prev
page 24 of 62
next →
Pain89
Neurology1
Phase 2
JBI-802
Neuroendocrine Tumors
Jubilant Therapeutics Inc
  • Phase 1
    JBZ-001
    Diffuse Large B-Cell Lymphoma Jabez Biosciences Inc
  • Phase 2
    JIN-A02
    Non-Small Cell Lung Cancer J Ints Bio Co Ltd
  • Phase 1
    JMKX-1899
    Colorectal Cancer HUYA Bioscience International LLC
  • Phase 3
    JNJ-1900
    Head And Neck Squamous Cell Carcinoma (HNSC)$JNJ JOHNSON & JOHNSON
  • Phase 1
    JPH-034
    Glioma J-Pharma Co Ltd
  • Phase 2
    JWATM-204
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 1
    JZP-3507
    Ependymoma$JAZZ Jazz Pharmaceuticals plc
  • Phase 1
    JZP-898
    Gastroesophageal (GE) Junction Carcinomas$JAZZ Jazz Pharmaceuticals plc
  • Phase 2
    Jankistomig
    Solid Tumor Ottimo Pharma Ltd
  • Phase 2
    KB-707
    Metastatic Melanoma$KRYS Krystal Biotech, Inc.
  • Preclinical
    KBX-114
    Gynecological Cancer Kaida BioPharma Inc
  • Preclinical
    KFPH-013
    Unspecified Cancer Jiangsu Carephar Pharmaceutical Co Ltd
  • Phase 1
    KGX-101
    Solid Tumor Shanghai KangaBio Co Ltd
  • Preclinical
    KIN-102
    Solid Tumor Kinimmune Inc
  • Phase 2
    KITE-363
    Diffuse Large B-Cell Lymphoma Kite Pharma Inc
  • Phase 2
    KITE-753
    Diffuse Large B-Cell Lymphoma$GILD GILEAD SCIENCES, INC.
  • Phase 1
    KK-2269
    Solid Tumor Kyowa Kirin Co Ltd
  • Preclinical
    KLS-3021
    Breast Cancer Kolon Life Science Inc
  • Preclinical
    KMD-111
    Breast Cancer KMD Bio Co Ltd
  • Phase 1
    KN-01
    Breast Cancer PendreaBio Inc
  • Preclinical
    KOP-101
    Prostate Cancer KOP Therapeutics Corp
  • Phase 1
    KPG-121
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Kangpu Biopharmaceuticals Ltd
  • Phase 1
    KQB-548
    Metastatic Colorectal Cancer Kumquat Biosciences Inc
  • Phase 2
    KSQ-001
    Head And Neck Squamous Cell Carcinoma (HNSC) KSQ Therapeutics Inc
  • Phase 2
    KSQ-004
    Acral Lentiginous Melanoma KSQ Therapeutics Inc
  • Phase 1
    KST-6051
    Metastatic Colorectal Cancer$KG Kestrel Group Ltd